GlassScriptPhysician profile
Bridget Mcgowan
NPI 1386185635
$11,177.18
in general payments reported to CMS, 2019-2025
7 companies · $3,168 in 2025
The $3,168 reported for 2025 was more than what 82% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $40.79 · 2023: $22.21 · 2024: $7,947 · 2025: $3,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,674 · Consulting Fee: $2,150 · Food and Beverage: $1,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,674.00 |
| Consulting Fee | $2,150.00 |
| Food and Beverage | $1,312.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Pharmaceuticals, INC. | $6,902.66 | 2024-2025 | |
| Itf Therapeutics LLC | $3,877.07 | 2024-2025 | |
| Biogen, INC. | $200.33 | 2022-2024 | Spinraza |
| Sarepta Therapeutics, INC. | $84.58 | 2024 | |
| Novartis Pharmaceuticals Corporation | $53.72 | 2025 | |
| Ns Pharma, INC. | $46.85 | 2024 | Viltepso |
| Livanova USA, INC. | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Mcgowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.